Back to Resource Library
Long-Acting Injectable Cabotegravir: Implementation science needed to advance this additional HIV prevention choice
8 August 2022
In this article, the authors outline priority areas for implementation research needed to inform the effective scale-up of cabotegravir for PrEP.